PT  - JOURNAL ARTICLE
AU  - Lars Godmann
AU  - Miriam Bollmann
AU  - Adelheid Korb-Pap
AU  - Ulrich König
AU  - Joanna Sherwood
AU  - Denise Beckmann
AU  - Katja Mühlenberg
AU  - Frank Echtermeyer
AU  - James Whiteford
AU  - Giulia De Rossi
AU  - Thomas Pap
AU  - Jessica Bertrand
TI  - Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling
AID  - 10.1136/annrheumdis-2019-216847
DP  - 2020 Apr 01
TA  - Annals of the Rheumatic Diseases
PG  - 481--489
VI  - 79
IP  - 4
4099  - http://ard.bmj.com/content/79/4/481.short
4100  - http://ard.bmj.com/content/79/4/481.full
SO  - Ann Rheum Dis2020 Apr 01; 79
AB  - Objective Syndecan-4 (sdc4) is a cell-anchored proteoglycan that consists of a transmembrane core protein and glucosaminoglycan (GAG) side chains. Binding of soluble factors to the GAG chains of sdc4 may result in the dimerisation of sdc4 and the initiation of downstream signalling cascades. However, the question of how sdc4 dimerisation and signalling affects the response of cells to inflammatory stimuli is unknown.Methods Sdc4 immunostaining was performed on rheumatoid arthritis (RA) tissue sections. Interleukin (IL)-1 induced extracellular signal-regulated kinases (ERK) phosphorylation and matrix metalloproteinase-3 production was investigated. Il-1 binding to sdc4 was investigated using immunoprecipitation. IL-1 receptor (IL1R1) staining on wild-type, sdc4 and IL1R1 knockout fibroblasts was performed in fluorescence-activated cell sorting analyses. A blocking sdc4 antibody was used to investigate sdc4 dimerisation, IL1R1 expression and the histological paw destruction in the human tumour necrosis factor-alpha transgenic mouse.Results We show that in fibroblasts, the loss of sdc4 or the antibody-mediated inhibition of sdc4 dimerisation reduces the cell surface expression of the IL-1R and regulates the sensitivity of fibroblasts to IL-1. We demonstrate that IL-1 directly binds to sdc4 and in an IL-1R-independent manner leads to its dimerisation. IL-1-induced dimerisation of sdc4 regulates caveolin vesicle-mediated trafficking of the IL1R1, which in turn determines the responsiveness to IL-1. Administration of antibodies (Ab) against the dimerisation domain of sdc4, thus, strongly reduces the expression IL1R1 on arthritic fibroblasts both in vitro and an animal model of human RA.Conclusion Collectively, our data suggest that Ab that specifically inhibit sdc4 dimerisation may support anti-IL-1 strategies in diseases such as inflammatory arthritis.